Zhejiang Jiuzhou Pharm Co Ltd (603456) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Zhejiang Jiuzhou Pharm Co Ltd (603456) has a cash flow conversion efficiency ratio of 0.056x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥496.86 Million ≈ $72.71 Million USD) by net assets (CN¥8.82 Billion ≈ $1.29 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 603456 market cap for the company's overall valuation and market capitalisation.
Zhejiang Jiuzhou Pharm Co Ltd - Cash Flow Conversion Efficiency Trend (2008–2025)
This chart illustrates how Zhejiang Jiuzhou Pharm Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Zhejiang Jiuzhou Pharm Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zhejiang Jiuzhou Pharm Co Ltd ranked by their cash flow conversion efficiency. Explore Zhejiang Jiuzhou Pharm Co Ltd cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Guobang Pharma Ltd
SHG:605507
|
0.037x |
|
Shenzhen Hymson Laser Intelligent Equipments Co Ltd
SHG:688559
|
0.057x |
|
Sapiens International Corporation NV
TA:SPNS
|
0.020x |
|
INTERNET IN.JP.ADR 1 ON
F:IIJ
|
0.110x |
|
UroGen Pharma Ltd
NASDAQ:URGN
|
0.249x |
|
Sineng Electric Co Ltd
SHE:300827
|
-0.028x |
|
Weifu High-Technology Group Co Ltd
SHE:000581
|
0.049x |
|
Wuxi Huaguang Boiler Co Ltd
SHG:600475
|
0.066x |
Annual Cash Flow Conversion Efficiency for Zhejiang Jiuzhou Pharm Co Ltd (2008–2025)
The table below shows the annual cash flow conversion efficiency of Zhejiang Jiuzhou Pharm Co Ltd from 2008 to 2025. View Zhejiang Jiuzhou Pharm Co Ltd (603456) stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥8.79 Billion ≈ $1.29 Billion |
CN¥1.82 Billion ≈ $266.94 Million |
0.208x | +80.17% |
| 2024-12-31 | CN¥8.61 Billion ≈ $1.26 Billion |
CN¥991.66 Million ≈ $145.11 Million |
0.115x | -27.75% |
| 2023-12-31 | CN¥8.53 Billion ≈ $1.25 Billion |
CN¥1.36 Billion ≈ $199.06 Million |
0.159x | -30.14% |
| 2022-12-31 | CN¥5.37 Billion ≈ $786.02 Million |
CN¥1.23 Billion ≈ $179.37 Million |
0.228x | +54.17% |
| 2021-12-31 | CN¥4.58 Billion ≈ $669.78 Million |
CN¥677.52 Million ≈ $99.14 Million |
0.148x | +14.09% |
| 2020-12-31 | CN¥3.09 Billion ≈ $451.60 Million |
CN¥400.39 Million ≈ $58.59 Million |
0.130x | -33.08% |
| 2019-12-31 | CN¥2.86 Billion ≈ $418.27 Million |
CN¥554.16 Million ≈ $81.09 Million |
0.194x | +103.41% |
| 2018-12-31 | CN¥2.78 Billion ≈ $406.52 Million |
CN¥264.78 Million ≈ $38.75 Million |
0.095x | +4.63% |
| 2017-12-31 | CN¥2.68 Billion ≈ $392.28 Million |
CN¥244.20 Million ≈ $35.73 Million |
0.091x | +71.11% |
| 2016-12-31 | CN¥2.57 Billion ≈ $375.60 Million |
CN¥136.65 Million ≈ $20.00 Million |
0.053x | -4.69% |
| 2015-12-31 | CN¥2.52 Billion ≈ $368.13 Million |
CN¥140.53 Million ≈ $20.56 Million |
0.056x | +769.79% |
| 2014-12-31 | CN¥1.58 Billion ≈ $231.68 Million |
CN¥10.17 Million ≈ $1.49 Million |
0.006x | -97.68% |
| 2013-12-31 | CN¥736.75 Million ≈ $107.81 Million |
CN¥203.86 Million ≈ $29.83 Million |
0.277x | +7.08% |
| 2012-12-31 | CN¥597.08 Million ≈ $87.37 Million |
CN¥154.28 Million ≈ $22.58 Million |
0.258x | +7.20% |
| 2011-12-31 | CN¥460.54 Million ≈ $67.39 Million |
CN¥111.01 Million ≈ $16.24 Million |
0.241x | -21.27% |
| 2010-12-31 | CN¥343.94 Million ≈ $50.33 Million |
CN¥105.30 Million ≈ $15.41 Million |
0.306x | -38.31% |
| 2009-12-31 | CN¥245.87 Million ≈ $35.98 Million |
CN¥122.03 Million ≈ $17.86 Million |
0.496x | +5.09% |
| 2008-12-31 | CN¥175.41 Million ≈ $25.67 Million |
CN¥82.84 Million ≈ $12.12 Million |
0.472x | -- |
About Zhejiang Jiuzhou Pharm Co Ltd
Zhejiang Jiuzhou Pharmaceutical Co., Ltd operates as contract development and manufacturing organization (CDMO) company in China and internationally. The company offers small molecules, drug products, and peptide CDMO services. It also involved in business related to supporting the development of new drugs and pharmaceuticals. It serves global pharmaceutical companies, biotechnology companies, an… Read more